A Cleveland Clinic study suggests GLP-1 weight loss drugs may help slow the spread of some obesity-related cancers.

GLP-1 medications were initially developed and prescribed to help manage blood sugar in people with Type 2 diabetes ...

GLP-1 drugs may be linked to a lower risk of cancer progression, according to new research that will be presented next week ...

Real-world data show that GLP-1 receptor agonists (GLP-1s) may reduce metastatic progression of certain obesity-related ...

GLP-1 drugs, such as Ozempic and Wegovy, may slow down the spread of obesity-related cancers, according to researchers ...

GLP‑1 medications remain one of the most popular weight loss drugs on the market, but new research suggests consistency may ...

Lilly said people on the next-generation weight loss medication across three different dosages achieved weight loss of 19% to ...

An interview discussing recent research on the association between GLP-1 receptor agonist use and the risk of atrial fibrillation.

GLP-1 drugs have been accused of stealing muscle along with fat, but the evidence suggests the scare may say more about ...

A team of researchers at the National Institutes of Health (NIH) have unveiled new details about the events GLP-1 receptor ...

A recent study found that using GLP-1 drugs, such as Ozempic and Mounjaro, can help reduce "food noise," which can support ...

Balding might make you blue — but this news won’t. A recent study suggests that a controversial liquid popular in biohacking ...